BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.115
+0.015 (1.36%)
Jan 28, 2026, 1:14 PM EST - Market open
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $9.9 million as of January 28, 2026. Its market cap has decreased by -12.42% in one year.
Market Cap
9.90M
Enterprise Value
5.41M
1-Year Change
-12.42%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has increased from $6.50M to $9.90M, an increase of 52.26%. That is a compound annual growth rate of 10.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 9.80M | -5.77% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 10.71M |
| TransCode Therapeutics | 10.70M |
| BiomX | 10.61M |
| CytoMed Therapeutics | 9.64M |
| PharmaCyte Biotech | 9.62M |
| Pulmatrix | 9.52M |
| Evogene | 9.34M |
| BioVie | 9.12M |